The risk of melanoma in patients with chronic lymphocytic leukemia; a population-based study

Guy Jr, 2015, Vital signs: melanoma incidence and mortality trends and projections—United States, 1982–2030, MMWR Morb Mortal Wkly Rep, 64, 591 https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf. Accessed February 10, 2019. CFaFACS. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2008/cancer-facts-and-figures-2008.pdf. Accessed February 10, 2019. CFaFACS. Gandini, 2005, Meta-analysis of risk factors for cutaneous melanoma: II. Sun Exposure, Eur J Cancer, 41, 45, 10.1016/j.ejca.2004.10.016 Umansky, 2012, Melanoma-induced immunosuppression and its neutralization Kubica, 2012, Melanoma in immunosuppressed patients Jensen, 1999, Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens, J Am Acad Dermatol, 40, 177, 10.1016/S0190-9622(99)70185-4 Hu, 2005, Skin cancer and non‐Hodgkin's lymphoma: examining the link, Dermatol Surg, 31, 76, 10.1097/00042728-200501000-00014 Zattra, 2009, Immunosuppression and melanocyte proliferation, Melanoma Res, 19, 63, 10.1097/CMR.0b013e328322fc20 Felicetti, 2008, The promyelocytic leukemia zinc finger–microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms, Cancer Res, 68, 2745, 10.1158/0008-5472.CAN-07-2538 Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat) version 8.3.5. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs excluding AK Custom Data (with additional treatment fields), Nov 2017 Sub (2000-2015) <Katrina/Rita Population Adjustment>- Linked To County Attributes - Total U.S., 1969-2016 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2018, based on the November 2017 submission. Brewer, 2010, Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma, Dermatol Surg, 36, 368, 10.1111/j.1524-4725.2009.01447.x Archibald, 2018, Management of melanoma in patients with chronic lymphocytic leukemia, Leuk Res, 71, 43, 10.1016/j.leukres.2018.07.003 McKenna, 2000, Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology?, Br J Dermatol, 143, 171, 10.1046/j.1365-2133.2000.03610.x Garbe, 2010, Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline, Eur J Cancer, 46, 270, 10.1016/j.ejca.2009.10.032 Mayer, 2017, Inaccuracies in SEER registry data on melanoma thickness, J Am Acad Dermatol, 77, e17, 10.1016/j.jaad.2017.01.061